Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0340
+0.0010 (3.03%)
At close: Mar 13, 2026
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 54.97 million as of March 13, 2026. Its market cap has increased by 16.38% in one year.
Market Cap
54.97M
Enterprise Value
49.21M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 54.97M, an increase of 44.41%. That is a compound annual growth rate of 22.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 54.97M | 6.80% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 79.98M |
| Radiopharm Theranostics | 77.97M |
| Cynata Therapeutics | 73.61M |
| Neurizon Therapeutics | 67.07M |
| Immutep | 66.32M |
| Prescient Therapeutics | 60.99M |
| Imugene | 59.48M |
| Amplia Therapeutics | 59.00M |